Evolving issues in oncology: Modernizing clinical trials for patientswith cancer

JAMA - Journal of the American Medical Association

Volumn 321, Issue 5, 2019, Pages 447-448

  Sharpless, Norman E ^a   Doroshow, James H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CANCER PREVENTION; CANCER RESEARCH; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL STUDY; COST CONTROL; DIFFERENTIAL DIAGNOSIS; FUNDING; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MALIGNANT NEOPLASM; MOLECULAR BIOLOGY; NATIONAL HEALTH ORGANIZATION; NOTE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; INTERSECTORAL COLLABORATION; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION;

CLINICAL TRIALS AS TOPIC; DRUG INDUSTRY; HUMANS; INTERSECTORAL COLLABORATION; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT SELECTION; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 85060580539     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.18938     Document Type: Note

References (10)

1. Keating P, Cambrosio A. From screening to clinical research: The cure of leukemia and the early development of the cooperative oncology groups, 1955-1966. Bull Hist Med. 2002;76(2):299-334. doi: 10.1353/bhm.2002.0074
2. Doroshow JH, Fine HA, Abbruzzese JL, et al; The National Cancer Advisory Board Clinical Trials Working Group. Restructuring the National Cancer Clinical Trials enterprise. https://www.cancer.gov/ about-nci/organization/ccct/about/ctwg-report. pdf. June 2005. Accessed January 8, 2019.
3. National Clinical Trials Network. National Cancer Institute website. https://www.cancer.gov/ research/areas/clinical-trials/nctn. Updated October 2, 2018. Accessed January 8, 2019.
4. Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med. 2018;378(13):1177-1188. doi:10.1056/NEJMoa1713709
5. Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111-121. doi:10.1056/ NEJMoa1804710
6. Hyman DM, Taylor BS, Baselga J. Implementing genome-driven oncology. Cell. 2017;168(4):584-599. doi:10.1016/j.cell.2016.12.015
7. Woodcock J, LaVange LM. Master protocols to study multiple therapies, multiple diseases, or both. N Engl J Med. 2017;377(1):62-70. doi:10.1056/ NEJMra1510062
8. NCI Community Oncology Research Program. National Cancer Institute website. https://ncorp.cancer.gov/. Accessed January 8, 2019.
9. Conley BA, Doroshow JH. Molecular analysis for therapy choice: NCI MATCH. Semin Oncol. 2014;41 (3):297-299. doi:10.1053/j.seminoncol.2014.05.002
10. Clinical Trials Reporting Program. National Cancer Institute website. https://www.cancer.gov/ about-nci/organization/ccct/ctrp. Accessed January 8, 2019.